ClinVar Genomic variation as it relates to human health
NM_014285.7(EXOSC2):c.89G>T (p.Gly30Val)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Pathogenic(1); Likely pathogenic(1); Uncertain significance(2)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_014285.7(EXOSC2):c.89G>T (p.Gly30Val)
Variation ID: 446202 Accession: VCV000446202.18
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 9q34.12 9: 130693880 (GRCh38) [ NCBI UCSC ] 9: 133569267 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 13, 2017 Oct 20, 2024 Jun 28, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_014285.7:c.89G>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_055100.2:p.Gly30Val missense NM_001282708.1:c.89G>T NP_001269637.1:p.Gly30Val missense NM_001282709.1:c.89G>T NP_001269638.1:p.Gly30Val missense NR_104230.1:n.121G>T non-coding transcript variant NC_000009.12:g.130693880G>T NC_000009.11:g.133569267G>T - Protein change
- G30V
- Other names
- -
- Canonical SPDI
- NC_000009.12:130693879:G:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Exome Aggregation Consortium (ExAC) 0.00002
Trans-Omics for Precision Medicine (TOPMed) 0.00004
The Genome Aggregation Database (gnomAD) 0.00006
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
EXOSC2 | - | - |
GRCh38 GRCh37 |
229 | 298 | |
LOC130002815 | - | - | - | GRCh38 | - | 42 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Jun 28, 2024 | RCV000515461.6 | |
Uncertain significance (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 2, 2024 | RCV002527440.14 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jan 05, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome
Affected status: yes
Allele origin:
germline
|
DASA
Accession: SCV002061305.1
First in ClinVar: Jan 22, 2022 Last updated: Jan 22, 2022 |
Comment:
The c.89G>T;p.(Gly30Val) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 446202; OMIM: 602238.0001; PMID: 26843489) … (more)
The c.89G>T;p.(Gly30Val) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 446202; OMIM: 602238.0001; PMID: 26843489) - PS4.The variant was observed to have arisen de novo (paternity confirmed) in a patient with the disease and no family history (PMID: 26843489) - PS2.The variant is present at low allele frequencies population databases (rs537467155– gnomAD 0.0005261%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Gly30Val) was detected in trans with a pathogenic variant (PMID: 26843489) - PM3. The variant co-segregated with disease in multiple affected family members (PMID: 26843489) - PP1_moderate. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic. (less)
Number of individuals with the variant: 1
Sex: female
Geographic origin: Brazil
|
|
Uncertain significance
(Jan 02, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003441393.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 30 of the EXOSC2 protein (p.Gly30Val). … (more)
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 30 of the EXOSC2 protein (p.Gly30Val). This variant is present in population databases (rs537467155, gnomAD 0.004%). This missense change has been observed in individuals with EXOSC2-related conditions (PMID: 26843489). ClinVar contains an entry for this variant (Variation ID: 446202). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EXOSC2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects EXOSC2 function (PMID: 31628467, 34162742). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Likely pathogenic
(Jun 28, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
unknown
|
Institute of Human Genetics, University of Leipzig Medical Center
Accession: SCV005368154.1
First in ClinVar: Oct 13, 2024 Last updated: Oct 13, 2024 |
Comment:
Criteria applied: PS3_SUP,PM2,PM3,PP3
Clinical Features:
Hearing impairment (present) , Failure to thrive (present) , Nephrotic syndrome (present) , Posteriorly rotated ears (present) , Large forehead (present) , Decreased circulating antibody … (more)
Hearing impairment (present) , Failure to thrive (present) , Nephrotic syndrome (present) , Posteriorly rotated ears (present) , Large forehead (present) , Decreased circulating antibody concentration (present) , Global developmental delay (present) , Macrocephaly (present) , Depressed nasal bridge (present) , Abnormality of the palmar creases (present) , Recurrent bronchitis (present) , Cow milk allergy (present) , Deeply set eye (present) (less)
Sex: male
|
|
Uncertain significance
(Jul 01, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004156521.10
First in ClinVar: Nov 20, 2023 Last updated: Oct 20, 2024 |
Comment:
EXOSC2: PP3, PS3:Supporting, PS4:Supporting
Number of individuals with the variant: 1
|
|
Pathogenic
(Oct 02, 2023)
|
no assertion criteria provided
Method: literature only
|
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000611547.2
First in ClinVar: Nov 13, 2017 Last updated: Oct 05, 2023 |
Comment on evidence:
In 2 patients from the same German family (family 1) with short stature, hearing loss, retinitis pigmentosa, and distinctive facies (SHRF; 617763), Di Donato et … (more)
In 2 patients from the same German family (family 1) with short stature, hearing loss, retinitis pigmentosa, and distinctive facies (SHRF; 617763), Di Donato et al. (2016) identified a homozygous c.89G-T transversion (c.89G-T, NM_014285.5) in exon 1 of the EXOSC2 gene, resulting in a gly30-to-val (G30V) substitution at a conserved residue in the NT domain. The G30V substitution was predicted to disrupt EXOSC2 protein interaction with EXOSC4 (606491). An unrelated patient from another German family (family 2) with a similar disorder was compound heterozygous for G30V and a c.593G-A transition in exon 7, resulting in a gly198-to-asp (G198D; 602238.0002) substitution at a conserved residue in the KH domain. The G198D variant was predicted to alter the beta-hairpin structure of the protein and possibly interfere with RNA recruiting and binding. The mutations, which were found by whole-exome sequencing, segregated with the disorder in both families. The G30V variant was found in heterozygous state in 1 of 1,000 local German control individuals (frequency of 0.0005) and at a low frequency in the ExAC database (0.00002), whereas G198D was not found in the German controls. Neither variant was found in the 1000 Genomes Project database. Functional studies of the variants and studies of patient cells were not performed. By Western blot and immunoprecipitation analyses, Yang et al. (2020) showed that the G198D mutation, but not the G30V mutation, decreased EXOSC2 protein stability and impaired its interactions with other RNA exosome components. Moreover, the G198V mutant protein was nonfunctional and was associated with compromised cell proliferation, as expression of the G198V mutant did not rescue decreased cell proliferation in EXOSC2-deficient keratinocytes. RNA-sequencing analysis identified several deregulated RNAs in SHRF patient B-lymphoblasts and EXOSC2-knockout primary cultured keratinocytes, indicating that EXOSC2 regulates RNA metabolism. Subsequent in vitro analysis revealed an autophagy defect in EXOSC2-deficient human cells. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A budding yeast model for human disease mutations in the EXOSC2 cap subunit of the RNA exosome complex. | Sterrett MC | RNA (New York, N.Y.) | 2021 | PMID: 34162742 |
Genetic and genomic studies of pathogenic EXOSC2 mutations in the newly described disease SHRF implicate the autophagy pathway in disease pathogenesis. | Yang X | Human molecular genetics | 2020 | PMID: 31628467 |
Mutations in EXOSC2 are associated with a novel syndrome characterised by retinitis pigmentosa, progressive hearing loss, premature ageing, short stature, mild intellectual disability and distinctive gestalt. | Di Donato N | Journal of medical genetics | 2016 | PMID: 26843489 |
Clinical and muscle biopsy findings in Norwegian paediatric patients with limb girdle muscular dystrophy 2I. | Rasmussen M | Acta paediatrica (Oslo, Norway : 1992) | 2014 | PMID: 24447024 |
FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. | Walter MC | Journal of medical genetics | 2004 | PMID: 15060126 |
Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum. | de Paula F | European journal of human genetics : EJHG | 2003 | PMID: 14647208 |
Text-mined citations for rs537467155 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.